Morphine-induced preconditioning: Involvement of protein kinase a and mitochondrial permeability transition pore

PLoS ONE

Volumn 11, Issue 3, 2015, Pages

  Dorsch, Marianne ^a   Behmenburg, Friederike ^a   Raible, Miriam ^a   Blase, Dominic ^a   Grievink, Hilbert ^a,d,e   Hollmann, Markus W ^b   Heinen, André ^a,c   Huhn, Ragnar ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACTYLOSIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN A; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MORPHINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN INHIBITOR; STAT3 PROTEIN; STATTIC; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; CARRIER PROTEIN; CYCLOSPORIN; ISOQUINOLINE DERIVATIVE; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; STAT3 PROTEIN, RAT; SULFONAMIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CARDIAC MUSCLE CELL; CELL ISOLATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN SYNTHESIS REGULATION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; DRUG EFFECTS; ENERGY METABOLISM; IN VITRO STUDY; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; REPERFUSION; WISTAR RAT;

ANIMALS; ATRACTYLOSIDE; CARDIOTONIC AGENTS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOSPORINE; ENERGY METABOLISM; IN VITRO TECHNIQUES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOQUINOLINES; MALE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MORPHINE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; RANDOM ALLOCATION; RATS, WISTAR; REPERFUSION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SULFONAMIDES;

EID: 84962271422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151025     Document Type: Article

References (32)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov; 74(5):1124-36. PMID: 3769170
2. Zhao Z-Q, Corvera JS, Halkos ME, Kerendi F, Wang N-P, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. American Journal of Physiology-Heart and Circulatory Physiology. 2003 Aug. 1;285(2):H579-88. PMID: 12860564
3. Cason BA, Gamperl AK, Slocum RE, Hickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology. 1997 Nov; 87(5):1182-90. PMID: 9366471
4. Müllenheim J, Ebel D, Frässdorf J, Preckel B, Thämer V, Schlack W. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology. 2002 Apr; 96(4):934-40. PMID: 11964602
5. Gross ER, Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res. 2006 May 1;70(2):212-21. PMID: 16448635
6. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditionving. Biochimica et Biophysica Acta (BBA)-Bioenergetics. 2007 Aug; 1767(8):1007-31.
7. Frässdorf J, Huhn R, Niersmann C, Weber NC, Schlack W, Preckel B, et al. Morphine induces preconditioning via activation of mitochondrial K (Ca) channels. Can J Anaesth. 2010 Aug; 57(8):767-73. doi: 10.1007/s12630-010-9325-1 PMID: 20461490
8. Huhn R, Heinen A, Weber NC, Schlack W, Preckel B, Hollmann MW. Ischaemic and morphine-induced post-conditioning: impact of mK (Ca) channels. Br J Anaesth. 2010 Nov; 105(5):589-95. doi: 10.1093/bja/aeq213 PMID: 20693178
9. Cao C-M, Xia Q, Gao Q, Chen M, Wong T-M. Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning. J Pharmacol ExpTher. 2005 Feb; 312(2):644-50. PMID: 15345753
10. Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S, et al. Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation. 2004 Jul. 6;110(1):51-7. PMID: 15210595
11. Sato T, Saito T, Saegusa N, Nakaya H. Mitochondrial Ca2+-activated K+channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A. Circulation. 2005 Jan 18;111(2):198-203. PMID: 15623543
12. Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W. The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg. 2005 Nov; 101(5):1252-60. PMID: 16243977
13. Toma O, Weber NC, Wolter JI, Obal D, Preckel B, Schlack W. Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. Anesthesiology. 2004 Dec; 101(6):1372-80. PMID: 15564945
14. Heinen A, Huhn R, Smeele KMA, Zuurbier CJ, Schlack W, Preckel B, et al. Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca (2+)-sensitive potassium channel activation. Anesthesiology. 2008 Nov; 109(5):830-6. doi: 10.1097/ALN.0b013e3181895aa0 PMID: 18946295
15. Huhn R, Weber NC, Preckel B, Schlack W, Bauer I, Hollmann MW, et al. Age-related loss of cardiac preconditioning: impact of protein kinase A. Exp Gerontol. 2012 Jan; 47(1):116-21. doi: 10.1016/j. exger.2011.11.003 PMID: 22100641
16. Gross ER, Hsu AK, Gross GJ. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3beta. Am J Physiol Heart Circ Physiol. 2006 Aug; 291(2):H827-34. PMID: 16517948
17. Puana R, McAllister RK, Hunter FA, Warden J, Childs EW. Morphine attenuates microvascular hyperpermeability via a protein kinase A-dependent pathway. Anesth Analg. 2008 Feb; 106(2):480-5, table of contents. doi: 10.1213/ane.0b013e318160648b PMID: 18227303
18. Zhang S, Wang N, Xu J, Gao Q, Lin G, Bruce IC, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology. 2006 Sep; 105(3):550-6. PMID: 16931988
19. Li J, Iorga A, Sharma S, Youn J-Y, Partow-Navid R, Umar S, et al. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A. Anesthesiology. 2012 Oct; 117(4):836-46. PMID: 22814384
20. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G. Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways. Circ Res. 2015 Jul. 17;117(3):279-88. doi: 10.1161/CIRCRESAHA.117.306878 PMID: 26058828
21. Redel A, Lange M, Jazbutyte V, Lotz C, Smul TM, Roewer N, et al. Activation of Mitochondrial Large-Conductance Calcium-Activated K+ Channels via Protein Kinase A Mediates Desflurane-Induced Preconditioning. Anesthesia & Analgesia February2008. 2008;106(2):384-91.
22. Muraki T, Uzumaki H, Kato R. Effect of morphine on the tissue cyclic AMP and cyclic GMP content in two strains of mice. J Pharm Pharmacol. 1984 Jul; 36(7):490-2. PMID: 6146702
23. Makaula S, Lochner A, Genade S, Sack MN, Awan MM, Opie LH. H-89, a non-specific inhibitor of protein kinase A, promotes post-ischemic cardiac contractile recovery and reduces infarct size. J Cardiovasc Pharmacol. 2005 Apr; 45(4):341-7. PMID: 15772523
24. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K (ATP) channels. Circ Res. 2001 Aug. 3;89(3):273-8. PMID: 11485978
25. Murphy E, Steenbergen C. Preconditioning: the mitochondrial connection. Annu Rev Physiol. 2007;69:51-67. PMID: 17007587
26. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003 Jan 12;60(3):617-25. PMID: 14659807
27. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, et al. Opening of mitochondrial K (ATP) channels triggers the preconditioned state by generating free radicals. Circ Res. 2000 Sep. 15;87(6):460-6. PMID: 10988237
28. Stowe DF, Aldakkak M, Camara AKS, Riess ML, Heinen A, Varadarajan SG, et al. Cardiac mitochondrial preconditioning by Big Ca2+-sensitive K+ channel opening requires superoxide radical generation. American Journal of Physiology-Heart and Circulatory Physiology. 2006 Jan 1;290(1):H434-40. PMID: 16126810
29. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 2004 Feb. 15;61(3):372-85. PMID: 14962470
30. Heinen A, Ströthoff M, Schmidt A, Stracke N, Behmenburg F, Bauer I, et al. Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA-BK (Ca) signaling pathway. Exp Gerontol. 2014 Aug; 56:99-105. doi: 10.1016/j.exger.2014.03.029 PMID: 24727217
31. Park SY, Kim J-H, Lee SJ, Kim Y. Involvement of PKA and HO-1 signaling in anti-inflammatory effects of surfactin in BV-2 microglial cells. Toxicol Appl Pharmacol. 2013 Apr. 1;268(1):68-78. doi: 10.1016/j. taap. 2013.01.017 PMID: 23360889
32. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol. 2010 Nov; 105(6):771-85. doi: 10.1007/s00395-010-0124-1 PMID: 20960209